GO:0050774 negative regulation of dendrite morphogenesis: Regulatory Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050774 (negative regulation of dendrite morphogenesis) describes any process that stops, prevents, or reduces the frequency, rate or extent of dendrite morphogenesis, a critical control point for neuronal circuit formation.
• The Wnt receptor Ryk acts as a cell-autonomous negative regulator of mammalian dendrite morphogenesis, restricting dendritic arbor growth in cortical neurons.
• Epigenetic factors CDYL and EZH2 coordinate to repress dendrite arborization, linking chromatin modification to dendritic patterning.
• MicroRNA-138 negatively regulates dendritic spine morphogenesis by targeting the depalmitoylation enzyme APT1, revealing post-transcriptional control of spine shape.
• Small GTPase signaling through Rac1 and Cdc42 is modulated by insulin receptor substrate p53 (IRSp53) to control dendritic spine morphogenesis.
• Disruption of negative regulatory mechanisms contributes to neurodevelopmental disorders and synaptic pathologies, making these pathways key research targets [2,4,7].
Description
Dendrite morphogenesis is the developmental process by which neurons extend and pattern their dendritic arbors to receive synaptic inputs. Equally important is the negative regulation of this process, which ensures that dendrites do not overgrow, mispattern, or form aberrant connections. GO:0050774, negative regulation of dendrite morphogenesis, captures the molecular and cellular events that stop, prevent, or reduce the frequency, rate, or extent of dendrite morphogenesis. This regulatory control is essential for establishing precise neural circuits, and its disruption is linked to neurodevelopmental and neurological disorders [2,4]. Research has identified diverse negative regulators, including the Wnt receptor Ryk, which cell-autonomously restricts dendritic arbor growth in mammalian cortical neurons, and epigenetic factors such as CDYL and EZH2 that repress dendrite arborization. At the post-transcriptional level, microRNA-138 negatively regulates dendritic spine morphogenesis by targeting APT1, while signaling through Rac1 and Cdc42 is modulated by IRSp53 to control spine morphogenesis. These examples illustrate that negative regulation of dendrite morphogenesis operates through multiple layers: receptor signaling, epigenetic silencing, microRNA-mediated repression, and cytoskeletal remodeling. Understanding these mechanisms is critical for deciphering how neuronal connectivity is established and how its dysregulation contributes to disease. This article provides a research-grade overview of GO:0050774, integrating authoritative GO definitions with verified PubMed literature to support experimental design and therapeutic exploration.
negative regulation of dendrite morphogenesis At A Glance
| GO ID | GO:0050774 |
|---|---|
| GO term | negative regulation of dendrite morphogenesis |
| Ontology | biological_process |
| Synonym | down regulation of dendrite morphogenesis, down-regulation of dendrite morphogenesis, downregulation of dendrite morphogenesis, inhibition of dendrite morphogenesis |
| Major function | Restricts dendritic arbor growth and patterning to ensure proper neuronal connectivity |
| Related processes | Dendrite morphogenesis, dendritic spine morphogenesis, neuronal development [2,5,7] |
| Key regulators | Ryk, CDYL, EZH2, miR-138, APT1, IRSp53, Rac1, Cdc42 [2,4,5,7] |
| Disease relevance | Neurodevelopmental disorders, synaptic dysfunction, neurological disease [2,4,7] |
What Is GO:0050774?
GO:0050774, negative regulation of dendrite morphogenesis, is defined as any process that stops, prevents, or reduces the frequency, rate or extent of dendrite morphogenesis. In other words, it encompasses all molecular and cellular mechanisms that put the brakes on the development and shaping of dendritic arbors, ensuring that dendrites attain appropriate size, complexity, and connectivity.
Why Is negative regulation of dendrite morphogenesis Important in Cell Biology?
Negative regulation of dendrite morphogenesis is fundamental for building precise neural circuits. Without inhibitory control, dendrites may overgrow or form aberrant synapses, leading to disrupted information processing. This process is implicated in neurodevelopmental disorders and synaptic pathologies, and understanding its mechanisms can reveal therapeutic targets for conditions characterized by dendritic abnormalities [2,4,7].
• Ensures proper dendritic arbor size and shape during brain development.
• Prevents aberrant synapse formation and maintains circuit specificity.
• Links epigenetic regulation to neuronal morphogenesis through CDYL and EZH2.
• Involves microRNA-mediated control of spine morphogenesis via miR-138 and APT1.
• Modulates small GTPase signaling through IRSp53, Rac1, and Cdc42.
• Dysregulation is associated with neurodevelopmental and synaptic disorders [2,4,7].
• Provides targets for therapeutic intervention in dendritic pathology [2,4].
• Essential for understanding experience-dependent plasticity and cognitive function [5,7].
What Happens During negative regulation of dendrite morphogenesis?
Receptor-mediated inhibition by Ryk
In simple terms: A receptor called Ryk acts as a brake on dendrite growth.
The Wnt receptor Ryk functions as a cell-autonomous negative regulator of mammalian dendrite morphogenesis. In cortical neurons, Ryk restricts dendritic arbor growth, and its loss leads to increased dendritic complexity. This indicates that Ryk-mediated signaling is a key inhibitory pathway in dendrite development.
Epigenetic repression by CDYL and EZH2
In simple terms: Proteins that modify chromatin work together to silence genes that promote dendrite growth.
CDYL and EZH2 coordinately regulate dendrite arborization. EZH2, a histone methyltransferase, and CDYL, a chromatin reader, cooperate to repress gene expression programs that drive dendrite growth, thereby negatively regulating dendrite morphogenesis.
MicroRNA-138 and APT1 in spine morphogenesis
In simple terms: A small RNA molecule reduces levels of a protein that controls spine shape.
MicroRNA-138 negatively regulates dendritic spine morphogenesis by targeting the depalmitoylation enzyme APT1. This post-transcriptional mechanism fine-tunes spine morphology, highlighting the role of microRNAs in negative regulation of dendrite morphogenesis.
IRSp53 and small GTPase signaling
In simple terms: A scaffold protein integrates signals from small GTPases to shape dendritic spines.
Insulin receptor substrate p53 (IRSp53) acts downstream of Rac1 and Cdc42 small GTPases to regulate dendritic spine morphogenesis. This pathway provides a mechanism for negative regulation of dendrite morphogenesis through cytoskeletal remodeling.
RhoA translation control by hnRNP-Q1
In simple terms: An RNA-binding protein controls production of a protein that inhibits dendrite growth.
hnRNP-Q1 negatively regulates RhoA translation and signaling, affecting cellular morphogenesis. This adds a translational layer of control to negative regulation of dendrite morphogenesis.
Key Genes Involved in GO:0050774 negative regulation of dendrite morphogenesis
The following genes and proteins have been experimentally implicated in negative regulation of dendrite morphogenesis.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Ryk | Wnt receptor that cell-autonomously restricts dendritic arbor growth | KO and overexpression models to study cortical dendrite patterning |
| CDYL | Chromatin reader that cooperates with EZH2 to repress dendrite arborization | Epigenetic regulation of dendrite morphogenesis |
| EZH2 | Histone methyltransferase that represses gene programs for dendrite growth | Chromatin modification in neuronal development |
| MIR138 | MicroRNA that targets APT1 to negatively regulate spine morphogenesis | Post-transcriptional control of spine shape |
| APT1 | Depalmitoylation enzyme regulated by miR-138 in spine morphogenesis | Lipid modification in dendritic spine regulation |
| IRSp53 | Scaffold protein downstream of Rac1 and Cdc42 in spine morphogenesis | Cytoskeletal signaling in dendrite development |
| Rac1 | Small GTPase modulating spine morphogenesis via IRSp53 | GTPase signaling in neuronal morphogenesis |
| Cdc42 | Small GTPase modulating spine morphogenesis via IRSp53 | GTPase signaling in neuronal morphogenesis |
| HNRNPQ | RNA-binding protein regulating RhoA translation | Translational control of morphogenesis |
| RhoA | Small GTPase whose translation is controlled by hnRNP-Q1 | Cytoskeletal dynamics in morphogenesis |
| Katanin | Microtubule-severing protein affecting synaptic plasticity | Microtubule regulation in neuronal function |
| Myeloid cells | Positive and negative regulation of dendritic cell lineage | Immune cell development (contextual) |
| Wnt signaling components | Pathway involving Ryk in dendrite morphogenesis | Signaling pathways in neuronal development |
| Epigenetic complex | CDYL/EZH2 complex repressing dendrite growth | Chromatin regulation in neurons |
| miR-138 target network | APT1 and related targets in spine morphogenesis | MicroRNA networks in neurons |
| Rac1/Cdc42 effectors | Downstream signaling to actin cytoskeleton | Cytoskeletal remodeling |
How Is negative regulation of dendrite morphogenesis Regulated?
Negative regulation of dendrite morphogenesis is itself subject to multiple layers of control. At the receptor level, Ryk-mediated Wnt signaling provides inhibitory cues. Epigenetic regulation by CDYL and EZH2 silences pro-growth gene programs. Post-transcriptional control by microRNA-138 modulates APT1 levels to restrict spine morphogenesis. Additionally, hnRNP-Q1 regulates RhoA translation, adding a translational layer. These mechanisms collectively ensure precise spatiotemporal control of dendrite development.
negative regulation of dendrite morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Ryk | Neurodevelopmental disorders with dendritic abnormalities | Ryk KO and overexpression in cortical neurons |
| CDYL/EZH2 | Epigenetic dysregulation in neurodevelopmental disorders | Conditional KO or knockdown in neurons |
| MIR138/APT1 | Synaptic dysfunction and spine pathologies | miR-138 mimic/inhibitor and APT1 mutants |
| IRSp53/Rac1/Cdc42 | Cytoskeletal signaling in neurological disease | Point mutants and GTPase inhibitors |
| Katanin | Synaptic plasticity defects | Katanin inhibition and KO models |
Neurodevelopmental disorders
Disruption of negative regulators such as Ryk or CDYL/EZH2 can lead to abnormal dendritic arborization, which is a hallmark of neurodevelopmental disorders. Studies in model systems suggest that loss of these brakes results in increased dendritic complexity and altered connectivity [2,4].
Synaptic dysfunction and neurological disease
MicroRNA-138-dependent regulation of APT1 in spine morphogenesis links negative regulation of dendrite morphogenesis to synaptic dysfunction. Dysregulation of this pathway may contribute to disorders characterized by spine abnormalities.
Cytoskeletal and signaling pathologies
Alterations in IRSp53, Rac1, or Cdc42 signaling can affect spine morphogenesis and are implicated in neurological conditions. Targeting these pathways may offer therapeutic avenues.
From negative regulation of dendrite morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of Ryk increase dendritic arborization? | Ryk knockout mouse or cortical neuron cultures |
| How does CDYL/EZH2 repress dendrite growth? | Conditional knockout or shRNA knockdown in neurons |
| What is the role of miR-138 in spine morphogenesis? | miR-138 overexpression or inhibition in neurons |
| How does IRSp53 mediate Rac1/Cdc42 signaling? | Point mutations in IRSp53 and GTPase mutants |
| Does hnRNP-Q1 regulate RhoA translation? | Knockdown and translational reporter assays |
| What is the effect of katanin inhibition on plasticity? | Katanin inhibitor treatment in neuronal cultures |
How to Study the negative regulation of dendrite morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Confocal microscopy | Dendritic arbor complexity and spine density | Assessing negative regulation in KO/overexpression models [2,4] |
| RNA-seq | Transcriptional changes | Identifying gene programs repressed by CDYL/EZH2 |
| CLIP-seq | RNA-protein interactions | Mapping miR-138 targets |
| Polysome profiling | Translational efficiency | Measuring RhoA translation control by hnRNP-Q1 |
| Live-cell imaging | Cytoskeletal dynamics | Studying IRSp53/Rac1/Cdc42 effects |
| FRAP | Protein turnover and mobility | Assessing katanin function in plasticity |
| Western blot | Protein expression levels | Validating knockdown or overexpression [2,5] |
| Immunofluorescence | Protein localization | Determining subcellular distribution [4,7] |
Imaging of dendritic morphology
Confocal or two-photon microscopy of fluorescently labeled neurons allows quantification of dendritic arbor complexity, spine density, and morphology. This is the primary method to assess negative regulation of dendrite morphogenesis [2,4,7].
Transcriptomic and epitranscriptomic profiling
RNA-seq and CLIP-seq can identify transcripts regulated by CDYL/EZH2 or microRNAs, revealing gene programs under negative regulation [4,7].
Proteomic and translational assays
Polysome profiling or Ribo-seq can measure translational control, such as RhoA translation regulated by hnRNP-Q1.
Live-cell imaging and FRAP
Live imaging of cytoskeletal dynamics and FRAP can assess how proteins like IRSp53 or katanin affect actin/microtubule remodeling during dendrite morphogenesis [5,8].
How CRISPR Can Be Used to Study GO:0050774 negative regulation of dendrite morphogenesis
Knockout
CRISPR knockout of negative regulators such as Ryk or CDYL can reveal their necessity in restricting dendrite growth. KO neurons typically show increased dendritic complexity, confirming their inhibitory role [2,4].
Point Mutation
Introducing point mutations in genes like IRSp53 or RhoA can dissect specific signaling domains required for negative regulation of dendrite morphogenesis [3,5].
Knock-in
Knock-in of fluorescent tags or epitope tags into endogenous loci (e.g., Ryk, EZH2) enables live imaging and proteomic analysis of these regulators in their native context [2,4].
Overexpression
Overexpression of negative regulators like miR-138 or Ryk can suppress dendrite growth, providing gain-of-function evidence for their inhibitory roles [2,7].
How EDITGENE Supports negative regulation of dendrite morphogenesis Research
Researchers studying negative regulation of dendrite morphogenesis-related genes often need to determine whether a candidate gene is causally involved in restricting dendritic growth. This requires precise genetic models that can knockout, mutate, tag, or overexpress the gene of interest in relevant neuronal systems.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of dendrite morphogenesis research.
Frequently Asked Questions About negative regulation of dendrite morphogenesis
What is GO:0050774?
GO:0050774 is the Gene Ontology term for negative regulation of dendrite morphogenesis, defined as any process that stops, prevents, or reduces the frequency, rate or extent of dendrite morphogenesis.
What genes are involved in negative regulation of dendrite morphogenesis?
Key genes include Ryk, CDYL, EZH2, MIR138, APT1, IRSp53, Rac1, Cdc42, and HNRNPQ, among others [2,3,4,5,7].
How does Ryk negatively regulate dendrite morphogenesis?
Ryk acts as a cell-autonomous negative regulator of mammalian dendrite morphogenesis, restricting dendritic arbor growth in cortical neurons.
What is the role of microRNA-138 in dendrite morphogenesis?
MicroRNA-138 negatively regulates dendritic spine morphogenesis by targeting the depalmitoylation enzyme APT1.
How do CDYL and EZH2 control dendrite arborization?
CDYL and EZH2 coordinately repress gene expression programs that drive dendrite growth, thereby negatively regulating dendrite morphogenesis.
What signaling pathways are involved in negative regulation of dendrite morphogenesis?
Wnt/Ryk signaling, small GTPase pathways (Rac1, Cdc42, RhoA), and epigenetic silencing complexes are key pathways [2,3,4,5].
Why is negative regulation of dendrite morphogenesis important for brain function?
It ensures proper dendritic arbor size and connectivity, preventing aberrant synapse formation and maintaining circuit specificity.
What diseases are associated with defects in negative regulation of dendrite morphogenesis?
Neurodevelopmental disorders, synaptic dysfunction, and neurological conditions characterized by dendritic abnormalities [2,4,7].
How can I study negative regulation of dendrite morphogenesis using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models in neurons can reveal gene function in this process [2,4,5,7].
What methods are used to measure negative regulation of dendrite morphogenesis?
Confocal imaging, RNA-seq, CLIP-seq, polysome profiling, and live-cell imaging are commonly used [2,3,4,5,7,8].
Conclusion
GO:0050774, negative regulation of dendrite morphogenesis, is a critical biological process that ensures proper neuronal connectivity by restricting dendritic growth. Key regulators such as Ryk, CDYL/EZH2, miR-138, and IRSp53 provide multiple layers of control. Understanding these mechanisms offers insights into neurodevelopmental disorders and potential therapeutic targets. EDITGENE provides comprehensive CRISPR services to facilitate research in this field.
References
- 2. Lanoue V et al.. 2017. The Wnt receptor Ryk is a negative regulator of mammalian dendrite morphogenesis.. Sci Rep 7(1):5965 PMID: 28729735
- 3. Xing L et al.. 2012. Negative regulation of RhoA translation and signaling by hnRNP-Q1 affects cellular morphogenesis.. Mol Biol Cell 23(8):1500-9 PMID: 22357624
- 4. Qi C et al.. 2014. Coordinated regulation of dendrite arborization by epigenetic factors CDYL and EZH2.. J Neurosci 34(13):4494-508 PMID: 24671995
- 5. Choi J et al.. 2005. Regulation of dendritic spine morphogenesis by insulin receptor substrate 53, a downstream effector of Rac1 and Cdc42 small GTPases.. J Neurosci 25(4):869-79 PMID: 15673667
- 7. Siegel G et al.. 2009. A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis.. Nat Cell Biol 11(6):705-16 PMID: 19465924
- 8. Lombino FL et al.. 2024. Functional Inhibition of Katanin Affects Synaptic Plasticity.. J Neurosci 44(13) PMID: 38050126
